More support for high-dose atorvastatin in coronary artery disease

被引:0
作者
Doggrell, SA [1 ]
机构
[1] Univ Auckland, Div Hlth Practice, Auckland 1, New Zealand
关键词
atorvastatin; clinical trials; coronary artery disease; magnetic resonance imaging;
D O I
10.1517/14656566.6.13.2365
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous studies have shown that intensive lipid lowering with atorvastatin has advantages over moderate lipid lowering with pravastatin in patients with coronary heart disease. An important question that remains is whether atorvastatin has advantages over other statins per se, or whether it is the dose of atorvastatin that is important. The Treating to New Targets (TNT) study compared atorvastatin 80 and 10 mg/day on clinical end points in patients with stable coronary disease. After a median follow up of 4.9 years, events (death from coronary heart disease, nonfatal myocardial infarction, resuscitation after cardiac arrest, or stroke) had occurred in 8.7% of the high-dose atorvastatin patients compared with 10.9% taking atorvastatin 10 mg/day. A magnetic resonance imaging study that compared the effects of atorvastatin 5 and 20 mg on aortic atherosclerosis showed that there was no effect with atorvastatin 5 mg over 12 months, suggesting prevention of progression, whereas atorvastatin 20 mg produced regression. These studies show that the dose of atorvastatin is important in coronary heart disease, with the more intensive the lipid-lowering, the greater the benefits with atorvastatin.
引用
收藏
页码:2365 / 2368
页数:4
相关论文
共 50 条
[31]   Effect of Atorvastatin on Cellular Adhesion Molecules on Leukocytes in Patients with Normocholesterolemic Coronary Artery Disease [J].
Walter, Thomas ;
Suselbeck, Tim ;
Borggrefe, Martin ;
Swoboda, Stefanie ;
Hoffmeister, Hans Martin ;
Dempfle, Carl-Erik .
IN VIVO, 2010, 24 (02) :189-193
[32]   Atorvastatin affects C-reactive protein levels in patients with coronary artery disease [J].
Karaca, I ;
Ilkay, E ;
Akbulut, M ;
Yavuzkir, M ;
Pekdemir, M ;
Akbulut, H ;
Arslan, N .
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (03) :187-191
[33]   The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease [J].
Yildiz A. ;
Cakar M.A. ;
Baskurt M. ;
Okcun B. ;
Guzelsoy D. ;
Coskun U. .
Cardiovascular Ultrasound, 5 (1)
[34]   Comment on Atorvastatin Safety in Kawasaki Disease Patients with Coronary Artery Aneurysms [J].
Adriana H. Tremoulet .
Pediatric Cardiology, 2014, 35 :93-93
[35]   Comment on Atorvastatin Safety in Kawasaki Disease Patients with Coronary Artery Aneurysms [J].
Tremoulet, Adriana H. .
PEDIATRIC CARDIOLOGY, 2014, 35 (01) :93-93
[36]   High-Dose Statin Therapy in Patients With Stable Coronary Artery Disease Treating the Right Patients Based on Individualized Prediction of Treatment Effect [J].
Dorresteijn, Johannes A. N. ;
Boekholdt, S. Matthijs ;
van der Graaf, Yolanda ;
Kastelein, John J. P. ;
LaRosa, John C. ;
Pedersen, Terje R. ;
DeMicco, David A. ;
Ridker, Paul M. ;
Cook, Nancy R. ;
Visseren, Frank L. J. .
CIRCULATION, 2013, 127 (25) :2485-2493
[37]   Effect of high-dose statin therapy on coagulation factors: Lowering of factor XI as a modifier of fibrin clot properties in coronary artery disease [J].
Stepien, Konrad ;
Siudut, Jakub ;
Konieczynska, Malgorzata ;
Nowak, Karol ;
Zalewski, Jaroslaw ;
Undas, Anetta .
VASCULAR PHARMACOLOGY, 2023, 149
[38]   Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography [J].
Ozhan, Hakan ;
Erden, Ismail ;
Ordu, Serkan ;
Aydin, Mesut ;
Caglar, Onur ;
Basar, Cengiz ;
Yalcin, Subhan ;
Alemdar, Recai .
ANGIOLOGY, 2010, 61 (07) :711-714
[39]   Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither [J].
Conard, S. ;
Bays, H. ;
Leiter, L. A. ;
Bird, S. ;
Lin, J. ;
Hanson, M. E. ;
Shah, A. ;
Tershakovec, A. M. .
DIABETES OBESITY & METABOLISM, 2010, 12 (03) :210-218
[40]   Effect of different doses of atorvastatin on collateral formation in coronary artery disease patients with coronary atherosclerosis [J].
Liu, Ling ;
Gao, Lei ;
Tan, Huilian ;
Qi, Yanchao ;
Cui, Dong ;
Wang, Zhen ;
Liu, Jun .
CORONARY ARTERY DISEASE, 2022, 33 (06) :473-478